Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

2.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
What is the Immune System?01:38

What is the Immune System?

127.1K
Overview
127.1K
Humoral Immune Responses01:36

Humoral Immune Responses

83.5K
Overview
83.5K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.3K
4.3K
Deleterious Substances in Aggregate01:25

Deleterious Substances in Aggregate

540
Deleterious substances in aggregates can be detrimental to the quality and durability of concrete. These substances include organic impurities like loam, which interfere with cement hydration and are usually present in the sand. These prevent a good bond between aggregate and cement paste. Organic impurities can be detected using the colorimetric test, where the darkness of a solution after agitation indicates the level of organic content.
Another type of impurity is clay and fine material that...
540

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An independent reader system that parallels critical steps of full automation capability for immunohematology testing.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2022
Same author

DEL phenotype.

Immunohematology·2017
Same author

Bloody Brilliant: A History of Blood Groups and Blood Groupers.

Immunohematology·2017
Same author

Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.

Immunohematology·2013
Same author

Education in transfusion medicine for medical students and doctors.

Vox sanguinis·2013
Same author

Exponential error reduction in pretransfusion testing with automation.

Transfusion·2012

Related Experiment Video

Updated: Jan 22, 2026

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

6.1K

Rh immune globulin: an interfering substance in compatibility testing.

Tony S Casina1, S G Sandler2, Stephen M Autenrieth3

  • 1Transfusion Medicine Business Field, Product Manager, Ortho Clinical Diagnostics.

Immunohematology
|June 28, 2019
PubMed
Summary

Rh immune globulin (RhIG) can interfere with blood test results, especially in pregnant women and newborns. Differentiating RhIG interference from alloimmune anti-D requires careful testing and clinical history review.

More Related Videos

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.3K
Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

15.0K

Related Experiment Videos

Last Updated: Jan 22, 2026

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

6.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.3K
Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

15.0K

Area of Science:

  • Transfusion Medicine
  • Immunology
  • Clinical Laboratory Science

Background:

  • Immunoglobulin therapies can interfere with pretransfusion testing.
  • Rh immune globulin (RhIG) is commonly administered to Rh-negative pregnant women.
  • Detection of anti-D in maternal or newborn plasma can occur post-RhIG administration.

Purpose of the Study:

  • To highlight the challenges in interpreting pretransfusion tests in patients treated with RhIG.
  • To emphasize the need for accurate differentiation between RhIG-induced and alloimmune anti-D.
  • To guide appropriate patient management when interfering antibodies are detected.

Main Methods:

  • Review of clinical scenarios involving RhIG administration and antibody detection.
  • Discussion of limitations in routine laboratory methods for antibody identification.
  • Emphasis on the necessity of combining qualitative and quantitative testing with clinical history.

Main Results:

  • RhIG administration frequently leads to the detection of anti-D in antibody screening tests.
  • Routine methods often cannot distinguish between RhIG-induced and alloimmune anti-D.
  • Interference can complicate the interpretation of test results and patient management.

Conclusions:

  • RhIG should be recognized as a potential interfering substance in antibody detection tests.
  • Accurate diagnosis requires a comprehensive approach including specialized testing and thorough clinical evaluation.
  • Proper management hinges on correctly identifying the source of detected anti-D antibodies.